{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:41:31Z","timestamp":1792237291286,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1124\/dmd.110.034637","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T03:22:29Z","timestamp":1284693749000},"page":"2147-2156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["A Simple Liquid Chromatography-Tandem Mass Spectrometry Method to Determine Relative Plasma Exposures of Drug Metabolites across Species for Metabolite Safety Assessments"],"prefix":"10.1016","volume":"38","author":[{"given":"Hongying","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Scott","family":"Obach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.110.034637_bib1","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1021\/tx900124j","article-title":"Interpretation and considerations on the safety evaluation of human drug metabolites","volume":"22","author":"Atrakchi","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.110.034637_bib2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/taap.2002.9440","article-title":"Drug metabolites in safety testing","volume":"182","author":"Baillie","year":"2002","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.110.034637_bib3","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1021\/tx060203m","article-title":"A regulatory perspective on issues and approaches in characterizing human metabolites","volume":"19","author":"Davis-Bruno","year":"2006","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.110.034637_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/clpt.2009.283","article-title":"Metabolites in safety testing: \u201cMIST\u201d for the clinical pharmacologist","volume":"87","author":"Frederick","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.110.034637_bib5","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1002\/rcm.3257","article-title":"Method for rapid metabolite profiling of drug candidates in fresh hepatocytes using liquid chromatography coupled with a hybrid quadrupole linear ion trap","volume":"21","author":"Gao","year":"2007","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.110.034637_bib6","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.chroma.2009.12.079","article-title":"Performance of columns packed with the new shell particles, Kinetex-C18","volume":"1217","author":"Gritti","year":"2010","journal-title":"J Chromatogr A"},{"key":"10.1124\/dmd.110.034637_bib7","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/rcm.1020","article-title":"Product ion scanning using a Q-q-Q linear ion trap (Q TRAP) mass spectrometer","volume":"17","author":"Hager","year":"2003","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.110.034637_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/clpt.1981.56","article-title":"Mean serum level determination by assay of a single pooled sample","volume":"29","author":"Hamilton","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.110.034637_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0041-008X(03)00150-9","article-title":"Drug metabolites in safety testing","volume":"190","author":"Hastings","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.110.034637_bib10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/js970486q","article-title":"Plasma-pooling methods to increase throughput for in vivo pharmacokinetic screening","volume":"87","author":"Hop","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.110.034637_bib11","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1021\/tx6002547","article-title":"Safety assessment of drug metabolites: characterization of chemically stable metabolites","volume":"19","author":"Humphreys","year":"2006","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.110.034637_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jchromb.2008.08.032","article-title":"Monitoring phospholipids for assessment of ion enhancement and ion suppression in ESI and APCI LC\/MS\/MS for chlorpheniramine in human plasma and the importance of multiple source matrix effect evaluations","volume":"875","author":"Ismaiel","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/dmd.110.034637_bib13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1021\/tx800432c","article-title":"Which human metabolites have we mist? Retrospective analysis, practical aspects, and perspectives for metabolite identification and quantification in pharmaceutical development","volume":"22","author":"Leclercq","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.110.034637_bib14","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/rcm.2008","article-title":"Simultaneously quantifying parent drugs and screening for metabolites in plasma pharmacokinetic samples using selected reaction monitoring information-dependent acquisition on a QTrap instrument","volume":"19","author":"Li","year":"2005","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.110.034637_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jchromb.2006.02.011","article-title":"Liquid chromatography-mass spectrometry\/mass spectrometry method development for drug metabolism studies: examining lipid matrix ionization effects in plasma","volume":"833","author":"Little","year":"2006","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/dmd.110.034637_bib16","series-title":"Proceedings of the 2009 AAPS Annual Meeting and Exposition; 2009 Nov 8\u201312; Los Angeles, CA","article-title":"Evaluation of generic chromatographic methodologies on phospholipid elution for bioanalytical applications using electrospray ionization","author":"Nouri","year":"2009"},{"key":"10.1124\/dmd.110.034637_bib17","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.4155\/bio.09.98","article-title":"Metabolites in safety testing","volume":"1","author":"Robison","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1124\/dmd.110.034637_bib18","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/jms.917","article-title":"A novel approach to perform metabolite screening during the quantitative LC-MS\/MS analyses of in vitro metabolic stability samples using a hybrid triple-quadrupole linear ion trap mass spectrometer","volume":"40","author":"Shou","year":"2005","journal-title":"J Mass Spectrom"},{"key":"10.1124\/dmd.110.034637_bib19","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1124\/dmd.105.005041","article-title":"Seeing through the mist: abundance versus percentage. Commentary on metabolites in safety testing","volume":"33","author":"Smith","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.034637_bib20","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1021\/tx0602012","article-title":"Metabolites and safety: what are the concerns, and how should we address them?","volume":"19","author":"Smith","year":"2006","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.110.034637_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1021\/tx00010a009","article-title":"Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment","volume":"2","author":"Smith","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.110.034637_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/tx8003328","article-title":"Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards","volume":"22","author":"Vishwanathan","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.110.034637_bib23","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1021\/tx900213j","article-title":"A holistic strategy for characterizing the safety of metabolites through drug discovery and development","volume":"22","author":"Walker","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.110.034637_bib24","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/rcm.1037","article-title":"Use of a quadrupole linear ion trap mass spectrometer in metabolite identification and bioanalysis","volume":"17","author":"Xia","year":"2003","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.110.034637_bib25","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/jms.1412","article-title":"Rapid screening and characterization of drug metabolites using a multiple ion monitoring-dependent MS\/MS acquisition method on a hybrid triple quadrupole-linear ion trap mass spectrometer","volume":"43","author":"Yao","year":"2008","journal-title":"J Mass Spectrom"},{"key":"10.1124\/dmd.110.034637_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/187231207783221411","article-title":"LC-MS\/MS-based approach for obtaining exposure estimates of metabolites in early clinical trials using radioactive metabolites as reference standards","volume":"1","author":"Zhang","year":"2007","journal-title":"Drug Metab Lett"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562402556X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562402556X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.110.034637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:54:05Z","timestamp":1739897645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562402556X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S009095562402556X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.110.034637","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Simple Liquid Chromatography-Tandem Mass Spectrometry Method to Determine Relative Plasma Exposures of Drug Metabolites across Species for Metabolite Safety Assessments","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.110.034637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}